1887

Abstract

Human papillomavirus types 6 and 11 (HPV-6 and HPV-11) are the major aetiological agents of condylomata acuminata. Serological studies of this disease have been difficult to perform and interpret because native, type-specific antigens have not been available. In particular, since these viruses have not been propagated and sufficient quantities of virions are not present in lesions, virus particles have been difficult to obtain. In the present study, we used HPV-11 particles, obtained from human tumours produced in athymic mice, as antigen in an ELISA to compare antibody responses between 46 patients with biopsy-proven condylomata acuminata and 44 controls. The median [interquartile range] of the absorbance values for the condylomata acuminata and the control groups were respectively 0.324 [0.183, 1.029] and 0.118 [0.047, 0.286] (=0.001). Thirty-three per cent of the absorbance values in the condylomata acuminata group were higher than any of those of the control group. Sera from patients whose biopsies contained the papillomavirus common antigen were more reactive than sera from patients whose biopsies did not contain it (=0.0014). This study demonstrates the presence of specific antibodies directed at native HPV-11 viral particles in the sera of patients with condylomata acuminata, and describes a test which can be used in future serological studies of this common sexually transmitted disease.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-72-6-1343
1991-06-01
2022-08-16
Loading full text...

Full text loading...

/deliver/fulltext/jgv/72/6/JV0720061343.html?itemId=/content/journal/jgv/10.1099/0022-1317-72-6-1343&mimeType=html&fmt=ahah

References

  1. Anisimová E., Bartak P., Vlček D., Hirsch I., Břicháček B., Vonka V. 1990; Presence and type specificity of papillomavirus antibodies demonstrable by immunoelectron microscopy tests in samples from patients with warts. Journal of General Virology 71:419–422
    [Google Scholar]
  2. Baird P. J. 1983; Serological evidence for the association of papillomavirus and cervical neoplasia. Lancet ii:17–18
    [Google Scholar]
  3. Beiss B. K., Sundberg J. P., Douglas J. M., Burk R. D., Ritter D. B., Kadish A. S. 1987; Host immune responses to genital and laryngeal human papillomavirus infections. Cancer Cells 5:387–392
    [Google Scholar]
  4. Bonnez W., Rose R. C., Reichman R. C., Strike D. G. 1990; The Pst I-Xho II restriction fragment of the HPV-6b L1 ORF lacks immunological specificity as determined by sera from HPV-6 condyloma acuminatum patients and controls. In UCLA Symposia on Molecular Cellular Biology, New Series vol 124 pp 77–80 Edited by Howley P., Broker T. New York: Alan R. Liss;
    [Google Scholar]
  5. Chow L. T., Nasseri M., Wolinsky S. M., Broker T. M. 1987; Human papillomavirus types 6 and 11 mRNAs from genital condylomata acuminata. Journal of Virology 61:2581–2588
    [Google Scholar]
  6. Favre M., Breitburd F., Croissant O., Orth G. 1975; Structural polypeptides of rabbit, bovine, and human papillomaviruses. Journal of Virology 15:1239–1247
    [Google Scholar]
  7. Gissmann L., Pfister H., Zur Hausen H. 1977; Human papillomaviruses: characterization of 4 different isolates. Virology 76:569–580
    [Google Scholar]
  8. Jenison S. A., Yu X., Valentine J. M., Galloway D. A. 1989; Human antibodies react with an epitope of the human papillomavirus type 6b L1 open reading frame which is distinct from the type-common epitope. Journal of Virology 63:809–818
    [Google Scholar]
  9. Jenison S. A., Yu X., Valentine J. M., Koutsky L. A., Christiansen A. E., Beckmann A. M., Galloway D. A. 1990; Evidence of prevalent genital-type human papillomavirus infections in adults and children. Journal of Infectious Diseases 162:60–69
    [Google Scholar]
  10. Jenson A. B., Rosenthal J. D., Olson C., Pass F., Lancaster W. D., Shah K. 1980; Immunologic relatedness of papillomaviruses from different species. Journal of the National Cancer Institute 64:495–500
    [Google Scholar]
  11. Johnson D. A., Gautsch J. W., Sportsman J. R., Elder J. H. 1984; Improved technique utilizing non-fat dry milk for analysis of proteins and nucleic acids transferred to nitrocellulose. Gene Analysis Techniques 1:3–8
    [Google Scholar]
  12. Kienzler J. L., Lemoine M. T., Orth G., Jibard N., Blanc D., Laurent R., Agache P. 1983; Humoral and cell-mediated immunity to human papillomavirus type 1 (HPV-1) in human warts. British Journal of Dermatology 108:665–672
    [Google Scholar]
  13. Kreider J. W., Howett M. K., Wolfe S. A., Bartlett G. L., Zaino R. J., Sedlacek T. V., Mortel R. 1985; Morphological transformation in vivo of human uterine cervix with papillomavirus from condylomata acuminata. Nature, London 317:639–641
    [Google Scholar]
  14. Kreider J. W., Howett M. K., Leure-Dupree A. E., Zaino R. J., Weber J. A. 1987; Laboratory production in vivo of infectious human papillomavirus type 11. Journal of Virology 61:590–593
    [Google Scholar]
  15. Li C. H., Shah K. V., Seth A., Gilden R. V. 1987; Identification of the human papillomavirus type 6b L1 open reading frame protein in condylomas and corresponding antibodies in human sera. Journal of Virology 61:2684–2690
    [Google Scholar]
  16. Miller M. F. II 1974; Particle counting of viruses. In Principles and Techniques of Electron Microscopy -Biological Applications pp 89128 Edited by Hayat M. A. New York: Van Nostrand Reinhold;
    [Google Scholar]
  17. Nel W. S., Fourie E. D. 1973; Immunotherapy and 5% topical 5-fluoro-uracil ointment in the treatment of condylomata acuminata. South Africa Medical Journal 47:45–49
    [Google Scholar]
  18. Ogilvie M. M. 1970; Serological studies with human papova (wart) virus. Journal of Hygiene 68:479–490
    [Google Scholar]
  19. Oriel D. 1990; Genital human papillomavirus infection. In Sexually Transmitted Diseases pp 433–441 Edited by Holmes K., Mardh P.-A., Sparling P. F., Wiesner P. J., Cates W. Jr, Lemon S. M., Stamm W. E. New York: McGraw-Hill;
    [Google Scholar]
  20. Orth G., Favre M. 1985; Human papillomavirus: biochemical and biological properties. Clinics in Dermatology 3:56–63
    [Google Scholar]
  21. Orth G., Favre M., Croissant O. 1977; Characterization of a new type of human papillomavirus that causes skin warts. Journal of Virology 24:108–120
    [Google Scholar]
  22. Orth G., Breitburd F., Favre M. 1978; Evidence for antigenic determinants shared by the structural polypeptides of (Shope) rabbit papillomavirus and human papillomavirus type 1. Virology 91:243–255
    [Google Scholar]
  23. Pfister H., Zur Hausen H. 1978; Seroepidemiological studies of human papilloma virus (HPV-1) infections. International Journal of Cancer 21:161–165
    [Google Scholar]
  24. Pfister H., Huchthausen B., Gross G., Zur Hausen H. 1979; Seroepidemiologic studies of bovine papillomavirus infections. Journal of the National Cancer Institute 62:1423–1425
    [Google Scholar]
  25. Pyrhӧnen S. 1978; Human wart-virus antibodies in patients with genital and skin warts. Acta dermato-venereologica 58:427–432
    [Google Scholar]
  26. Pyrhӧnen S., Jablonska S., Obalek S. 1980; Immune reactions in epidermodysplasia verruciformis. British Journal of Dermatology 102:247–254
    [Google Scholar]
  27. Reichman R. C., Bonnez W. 1990; Papillomaviruses. In Principles and Practice of Infectious Diseases pp 1191–1200 Edited by Mandell G. L., Douglas R. G. Jr, Bennett J. E. New York: Churchill Livingstone;
    [Google Scholar]
  28. Reichman R. C., Oakes D., Bonnez W., Brown D., Mattison H. R., Bailey-Farchione A., Stoler M. H., Demeter L. M., Tyring S. K., Miller L., Whitley R., Carveth H., Weidner M., Krueger G., Choi A. 1990; Treatment of condyloma acuminatum with three different alpha interferon preparations administered parenterally: a double-blind, placebo-controlled trial. Journal of Infectious Diseases 162:248–258
    [Google Scholar]
  29. Rodbard D. 1974; Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays. Clinical Chemistry 20:1255–1270
    [Google Scholar]
  30. Steele J. C., Gallimore P. H. 1990; Humoral assays of human sera to disrupted and nondisrupted epitopes of human papillomavirus type 1. Virology 174:388–398
    [Google Scholar]
  31. Strike D. G., Bonnez W., Rose R. C., Reichman R. C. 1989; Expression in Escherichia coli of seven DNA fragments comprising the complete L1 and L2 open reading frames of human papillomavirus type 6b and the location of the ‘common antigen’ region. Journal of General Virology 70:543–555
    [Google Scholar]
  32. Viac J., Thivolet J., Hegazy M. R., Chardonnet Y., Dambuyant C. 1977; Comparative study of delayed hypersensitivity skin reactions and antibodies to human papilloma virus (HPV). Clinical and Experimental Immunology 29:240–246
    [Google Scholar]
  33. Viac J., Staquet M. J., Miquet M., Chabanon M., Thivolet J. 1978; Specific immunity to human papilloma virus (HPV) in patients with genital warts. British Journal of Venereal Diseases 54:172–175
    [Google Scholar]
  34. Viac J., Chomel J.-J., Chardonnet Y., Aymard M. 1990; Incidence of antibodies to human papillomavirus type 1 in patients with cutaneous and mucosal papillomas. Journal of Medical Virology 32:18–21
    [Google Scholar]
  35. Voller A., Bidwell D. E., Bartlett A. 1976; Enzyme immunoassays in diagnostic medicine. Theory and practice. Bulletin of the World Health Organization 53:55–65
    [Google Scholar]
  36. Wilbur D. C., Reichman R. C., Stoler M. H. 1988; Detection of infection by human papillomavirus in genital condylomata. A comparison study using immunocytochemistry and in situ nucleic acid hybridization. American Journal of Clinical Pathology 89:505–510
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-72-6-1343
Loading
/content/journal/jgv/10.1099/0022-1317-72-6-1343
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error